MabPlex International

MabPlex International inaugurated a new Phase III and commercial manufacturing facility in Yantai, Shandong, China. The facility adds 400,000 ft² of cGMP space with six cell culture suites and four purification suites.

MabPlex USA, a subsidiary of MabPlex International, announced the opening of a new Process Development Center of Excellence in La Jolla, San Diego, California, with scale-up capacity to 200L. The facility will support cell line development and biologics manufacturing.